Benzoylaconine: Potential Therapeutic Agent for Cardiovascular Diseases From Fuzi
Modern pharmacological studies have elucidated the presence of aconitine (AC) alkaloids, polysaccharides, and saponins as the primary bioactive constituents of Fuzi. Among these, benzoylaconine, a pivotal active compound, demonstrates notable pharmacological properties including antitumor, anti-infl...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | Cardiovascular Therapeutics |
| Online Access: | http://dx.doi.org/10.1155/2024/4878103 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832546145661878272 |
|---|---|
| author | Chenggang Xu Le Tang Lixin Hu Yunzhe Huang Jin Tang Xiaohu Wang Feng Wang |
| author_facet | Chenggang Xu Le Tang Lixin Hu Yunzhe Huang Jin Tang Xiaohu Wang Feng Wang |
| author_sort | Chenggang Xu |
| collection | DOAJ |
| description | Modern pharmacological studies have elucidated the presence of aconitine (AC) alkaloids, polysaccharides, and saponins as the primary bioactive constituents of Fuzi. Among these, benzoylaconine, a pivotal active compound, demonstrates notable pharmacological properties including antitumor, anti-inflammatory, and cardiovascular protective effects. In recent years, benzoylaconine has garnered significant attention in basic research on heart diseases, emerging as a focal point of investigation. This paper presents a comprehensive review of the pharmacological effects of benzoylaconine, alongside an overview of advancements in metabolic characterization. The objective is to furnish valuable insights that can serve as a cornerstone for further exploration, utilization, and advancement of benzoylaconine in pharmacological research. |
| format | Article |
| id | doaj-art-8f3453b729e445359c25968963cee6f5 |
| institution | Kabale University |
| issn | 1755-5922 |
| language | English |
| publishDate | 2024-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Cardiovascular Therapeutics |
| spelling | doaj-art-8f3453b729e445359c25968963cee6f52025-02-03T07:23:45ZengWileyCardiovascular Therapeutics1755-59222024-01-01202410.1155/2024/4878103Benzoylaconine: Potential Therapeutic Agent for Cardiovascular Diseases From FuziChenggang Xu0Le Tang1Lixin Hu2Yunzhe Huang3Jin Tang4Xiaohu Wang5Feng Wang6Department of CardiologyPharmacology CollegeDepartment of PharmaceuticsGraduate SchoolGraduate SchoolDepartment of PharmaceuticsDepartment of CardiologyModern pharmacological studies have elucidated the presence of aconitine (AC) alkaloids, polysaccharides, and saponins as the primary bioactive constituents of Fuzi. Among these, benzoylaconine, a pivotal active compound, demonstrates notable pharmacological properties including antitumor, anti-inflammatory, and cardiovascular protective effects. In recent years, benzoylaconine has garnered significant attention in basic research on heart diseases, emerging as a focal point of investigation. This paper presents a comprehensive review of the pharmacological effects of benzoylaconine, alongside an overview of advancements in metabolic characterization. The objective is to furnish valuable insights that can serve as a cornerstone for further exploration, utilization, and advancement of benzoylaconine in pharmacological research.http://dx.doi.org/10.1155/2024/4878103 |
| spellingShingle | Chenggang Xu Le Tang Lixin Hu Yunzhe Huang Jin Tang Xiaohu Wang Feng Wang Benzoylaconine: Potential Therapeutic Agent for Cardiovascular Diseases From Fuzi Cardiovascular Therapeutics |
| title | Benzoylaconine: Potential Therapeutic Agent for Cardiovascular Diseases From Fuzi |
| title_full | Benzoylaconine: Potential Therapeutic Agent for Cardiovascular Diseases From Fuzi |
| title_fullStr | Benzoylaconine: Potential Therapeutic Agent for Cardiovascular Diseases From Fuzi |
| title_full_unstemmed | Benzoylaconine: Potential Therapeutic Agent for Cardiovascular Diseases From Fuzi |
| title_short | Benzoylaconine: Potential Therapeutic Agent for Cardiovascular Diseases From Fuzi |
| title_sort | benzoylaconine potential therapeutic agent for cardiovascular diseases from fuzi |
| url | http://dx.doi.org/10.1155/2024/4878103 |
| work_keys_str_mv | AT chenggangxu benzoylaconinepotentialtherapeuticagentforcardiovasculardiseasesfromfuzi AT letang benzoylaconinepotentialtherapeuticagentforcardiovasculardiseasesfromfuzi AT lixinhu benzoylaconinepotentialtherapeuticagentforcardiovasculardiseasesfromfuzi AT yunzhehuang benzoylaconinepotentialtherapeuticagentforcardiovasculardiseasesfromfuzi AT jintang benzoylaconinepotentialtherapeuticagentforcardiovasculardiseasesfromfuzi AT xiaohuwang benzoylaconinepotentialtherapeuticagentforcardiovasculardiseasesfromfuzi AT fengwang benzoylaconinepotentialtherapeuticagentforcardiovasculardiseasesfromfuzi |